Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 874

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 4
Chunk 874
---
 -  
     -  
     -  
     - 
  
    Issuance of Warrants 
     -  
     -  
     5,950,000  
     -  
     5,950,000 
  
    Net loss 
     -  
     -  
     -  
     (13,071,864) 
     (13,071,864)
  
    Balances, December 31, 2023 
     28,609,814  
     -  
     17,502,346  
     (14,064,142) 
     3,438,204 
  
    Balances 
     28,609,814  
     -  
     17,502,346  
     (14,064,142) 
     3,438,204 

    Issuance of common stock, net 
     1,142,857  
     -  
     6,832,973  
     -  
     6,832,973 
  
    Exercise of Warrants 
     10,000  
     -  
     37,300  
     -  
     37,300 
  
    Stock compensation 
        
     -  
     6,867,276  
     -  
     6,867,276 
  
    Net loss 
     -  
     -  
     -  
     (16,532,716) 
     (16,532,716)
  
    Balances, December 31, 2024 
     29,762,671  
    $-  
    $31,239,895  
    $(30,596,858) 
    $643,037 
  
    Balances 
     29,762,671  
    $-  
    $31,239,895  
    $(30,596,858) 
    $643,037 

The
accompanying notes to the financial statements are an integral part of these statements.

F-5

Telomir
Pharmaceuticals, Inc.

statements
of cash flows

    2024  
    2023 

    Year
    Ended December 31,